HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Regulation of P-glycoprotein by miR-27a-3p at the Brain Endothelial Barrier.

Abstract
Multi-drug resistance P-glycoprotein (P-gp/MDR1) is one of the most clinically relevant ABC transporters, highly enriched at the blood-brain barrier (BBB) with a broad substrate spectrum including therapeutic drugs and metabolic waste products. Altered P-gp transport function has been implicated in multi-drug resistance and in the pathogenesis and progression of neurological diseases. Recent studies have shown that P-gp expression is modulated by micro-RNAs in peripheral organs. Particularly, miR-27a-3p has been shown to play a critical role in the regulation of P-gp in multi-drug resistant cancer cells. In brain disorders, altered levels of miR-27a-3p were reported in several diseases associated with alterations in P-gp expression at the BBB. However, effect of altered miR-27a-3p expression on P-gp expression at the BBB remains to be determined. In this study, we investigated the role of miR-27a-3p in the regulation of P-gp expression and activity at the brain endothelium. Levels of miR-27a-3p were modulated by mimic and inhibitor transfection in an in-vitro model of human brain endothelial hCMEC/D3 cells. Effect of miR-27a-3p modulation on P-gp expression and activity was examined and the underlying regulatory mechanisms explored. Our results showed that transfection of hCMEC/D3 cells with miR-27a-3p mimic induces expression and activity of P-gp while miR-27a-3p inhibition exerted opposite effects. Mechanistic studies revealed that miR-27a-3p regulates P-gp by mediating Glycogen Synthase Kinase 3 Beta (GSK3ß) inhibition and activating Wnt/ß-catenin signaling. These findings shed light on miR-27a-3p/GSK3ß/ß-catenin as a novel axis that could be exploited to modulate P-gp efflux activity at the brain endothelium and help improving CNS diseases treatment or brain protection.
AuthorsSaba Hammad, Aloïse Mabondzo, Rifat Hamoudi, Rania Harati
JournalJournal of pharmaceutical sciences (J Pharm Sci) Vol. 111 Issue 5 Pg. 1470-1479 (05 2022) ISSN: 1520-6017 [Electronic] United States
PMID34695419 (Publication Type: Journal Article)
CopyrightCopyright © 2021. Published by Elsevier Inc.
Chemical References
  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Catenins
  • MicroRNAs
Topics
  • ATP Binding Cassette Transporter, Subfamily B, Member 1 (genetics, metabolism)
  • Brain (metabolism)
  • Catenins (metabolism)
  • Drug Resistance, Multiple
  • Drug Resistance, Neoplasm
  • Endothelium (metabolism)
  • Humans
  • MicroRNAs (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: